Semler Scientific, Inc. Q1 FY2025 Earnings Call

· Earnings call transcript and AI-powered summary

  • Total Revenue: $8.8 million, a 44% decrease from Q1 2024 due to CMS payment changes affecting test reimbursements.
  • Operating Expenses: Increased significantly to $39.9 million (vs. $8.9 million in Q1 2024), largely due to:
    • $29.8 million contingency reserve related to proposed DOJ settlement.
    • $1.5 million in non-cash stock compensation.
    • $0.4 million in sales tax accruals and $0.4 million in legal fees.
  • Loss from Operations: $31.1 million compared to Q1 2024 income from operations of $70 million.
  • Net Loss: $64.7 million, or $6.74 per share (basic and fully diluted) vs net income of $6.1 million or $0.88 per share (basic) and $0.78 (diluted) in Q1 2024.
  • Other Expenses: $43.8 million, largely due to a $41.8 million unrealized bitcoin loss due to fair value accounting.
  • Bitcoin Holdings:
    • Currently holds 3,808 bitcoins valued at approximately $400 million.
    • Q1 2025 acquisitions: 1,510 bitcoins with a BTC yield of 22.2%, resulting in a gain of 510 bitcoins and $52 million in value.
    • Total BTC gain since adopting bitcoin standard (May 28, 2024): 1,447 bitcoins and $139 million gain (152.8% yield).

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Good afternoon and welcome to the Semler Scientific First Quarter 2025 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded. Before we begin, Semler Scientific needs to remind you that certain comments made during this call may constitute forward-looking statements and are made pursuant to and within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. These include express or imply statements regarding the expectations for our Bitcoin treasury strategy, plans to acquire additional Bitcoin, opportunity to upsize and the price of Bitcoin. Expansion on the health care business and the development and marketing of additional products including receipt and timing of an additional 510(k) clearance for QuantaFlo. And for our proposed settlement with the U.S. Department of Justice. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements. Those risks and uncertainties are described in the press release and our SEC filings. The forward-looking statements made today are as of the date of this call and the company does not undertake any obligation to update the forward-looking statements. If you do not have a copy of today's release, you may obtain one by visiting the investor relations page of the website semlerscien

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional